TickerGuard
Buy Day today: Neutral (55) Mixed market breadth · no major macro event
ADAG

Adagene Inc

Healthcare · Biotechnology

3.20$ +9.2% vs. previous close Closing price · As of: Sep 28, 2026

Statements

Balance Sheet

Adagene Inc (ADAG) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 78 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet ADAG
Line item 2018 2019 2020 2021 2022 2023 2024 2025
54 106 84 190 152 116 89 78
52 104 79 186 149 113 88 77
16 93 75 174 144 110 85 75
49 101 75 174 144 110 85 75
1.4 2.1 0.1 7.5 0.6 0.2 0.0 0.0
– 0.0 – 0.0 – – – –
2.6 1.9 2.1 3.5 3.0 – – –
95 163 174 33 69 45 39 43
10 7.2 16 30 55 31 38 25
2.3 1.0 5.0 4.5 14 8.6 18 5.1
0.6 0.7 1.8 3.3 3.7 3.1 4.2 2.9
– 1.5 3.0 3.0 14 14 0.4 1.1
-41 -57 -89 157 83 71 51 35
-47 -63 -106 -179 -259 -278 -311 -329
9.7 35 28 32 35 35 36 38

Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?